Imaflex (IFX) AI Stock Analysis

• Market Cap: C$118.76M
• Dividend Yield: N/A
• Average Volume (3M): 11.13K
• Price to Earnings (P/E): 89.1
• Beta (1Y): 0.20
• Revenue Growth: 0.32%
• EPS Growth: -76.77%
• Country: CA
• Employees: 269
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Packaging & Containers
• EPS (TTM): 0.01
• Shares Outstanding: 52,088,640
• 10 Day Avg. Volume: 1,730
• 30 Day Avg. Volume: 11,130
• PEG Ratio: <0.01
• Price to Book (P/B): 1.14
• Price to Sales (P/S): 0.67
• P/FCF Ratio: 6.10
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 47 Neutral
• Price Target: C$2.00 ▼(-12.28% Downside)

Imaflex's overall stock score is primarily impacted by its high valuation and bearish technical indicators. The financial performance shows operational efficiency but highlights challenges in revenue growth and cash flow generation. The lack of earnings call and corporate events data limits further insights.

Positive Factors

Operational Efficiency

Imaflex's ability to maintain positive EBIT and EBITDA margins indicates strong operational efficiency, which supports long-term profitability despite revenue challenges.

Stable Balance Sheet

A stable balance sheet with low leverage suggests prudent financial management, providing resilience and flexibility for future growth opportunities.

Market Diversification

Imaflex's diverse customer base across multiple sectors reduces dependency on a single market, enhancing revenue stability and reducing risk.

Negative Factors

Declining Revenue Growth

A declining revenue growth rate may indicate challenges in maintaining sales momentum, potentially impacting long-term market position and profitability.

Profit Margin Pressure

Decreased profit margins suggest pressure on profitability, which could affect the company's ability to reinvest in growth and innovation.

Cash Flow Challenges

Challenges in free cash flow growth may limit Imaflex's ability to fund new investments and manage financial obligations, affecting future growth prospects.

Imaflex Business Overview & Revenue Model

Company Description

Imaflex Inc. is a Canadian manufacturer specializing in flexible packaging solutions and agricultural films. The company operates primarily in two segments: the flexible packaging sector, which produces a variety of plastic films and bags for food and consumer products, and the agricultural sector, which focuses on innovative film products for crop protection and productivity enhancement. Imaflex is committed to sustainability and innovation, providing eco-friendly packaging alternatives to meet the growing demands of various industries.

How the Company Makes Money

Imaflex generates revenue primarily through the sale of its flexible packaging products and agricultural films. The company has established a diverse customer base that includes food processors, retailers, and agricultural producers, allowing it to capture various market segments. Key revenue streams come from direct sales of custom and standard packaging solutions, which are often tailored to meet specific customer needs. Additionally, Imaflex benefits from ongoing partnerships with major players in the food and agricultural industries, enhancing its market reach and stability. The company's commitment to research and development also plays a significant role in its earnings, as it frequently introduces new products that cater to emerging market trends, thereby driving additional sales.

Imaflex Financial Statement Overview

Summary

Imaflex's financial statements present a mixed picture. The company faces challenges in revenue growth and profitability, as evidenced by declining margins and net income. However, it maintains a strong balance sheet with low leverage and a solid equity base, providing a cushion against financial volatility. Cash flow generation is a concern, with negative free cash flow growth, which may impact future strategic initiatives. Overall, while the company is financially stable, it needs to address profitability and cash flow challenges to enhance its financial performance.

Income Statement

Imaflex's income statement shows mixed performance. The TTM data indicates a decline in revenue growth rate by -2.19%, reflecting potential challenges in maintaining sales momentum. Gross profit margin has decreased to 14.51% from 16.35% in the previous annual report, indicating pressure on cost management or pricing power. Net profit margin also fell to 2.06% from 6.79%, suggesting reduced profitability. However, the company maintains a positive EBIT and EBITDA margin, though both have decreased compared to the previous year, indicating operational efficiency challenges.

Balance Sheet

The balance sheet remains relatively strong with a low debt-to-equity ratio of 0.14, indicating conservative leverage and financial stability. Return on equity has decreased to 3.51% in the TTM, down from 11.54% in the previous year, reflecting reduced profitability on shareholder investments. The equity ratio stands at 71.42%, showcasing a solid equity base relative to total assets, which is a positive indicator of financial health.

Cash Flow

Cash flow analysis reveals some concerns. The free cash flow growth rate is negative at -10.85% in the TTM, indicating challenges in generating cash after capital expenditures. The operating cash flow to net income ratio is slightly above 1, suggesting adequate cash generation relative to net income. However, the free cash flow to net income ratio is 0.79, indicating that not all net income is translating into free cash flow, which could impact future investments or debt repayments.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	108.00M	109.85M	93.59M	111.53M	107.48M	86.68M
Gross Profit	15.45M	17.97M	11.01M	18.05M	17.40M	16.57M
EBITDA	8.48M	14.44M	6.02M	15.62M	14.19M	12.88M
Net Income	1.34M	7.46M	508.78K	9.13M	8.37M	6.35M
Balance Sheet
Total Assets	90.67M	96.09M	78.45M	72.00M	64.99M	54.06M
Cash, Cash Equivalents and Short-Term Investments	11.92M	8.96M	799.13K	7.53M	8.47M	3.22M
Total Debt	8.42M	10.13M	11.41M	8.03M	9.57M	9.79M
Total Liabilities	25.95M	31.42M	22.59M	16.85M	19.92M	18.08M
Stockholders Equity	64.72M	64.67M	55.86M	55.15M	45.07M	35.98M
Cash Flow
Free Cash Flow	10.56M	12.03M	-7.58M	2.67M	5.58M	10.30M
Operating Cash Flow	13.89M	15.79M	5.44M	17.27M	8.05M	11.96M
Investing Cash Flow	-3.31M	-3.75M	-13.02M	-14.60M	-2.47M	-1.61M
Financing Cash Flow	-2.56M	-3.93M	859.92K	-3.62M	-304.06K	-7.16M

Imaflex Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 2.28
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:IFX, the sentiment is Positive. The current price of 2.28 is above the 20-day moving average (MA) of 1.33, above the 50-day MA of 1.20, and above the 200-day MA of 1.22, indicating a bullish trend. The MACD of 0.26 indicates Negative momentum. The RSI at 90.04 is Negative, neither overbought nor oversold. The STOCH value of 98.67 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:IFX.

Imaflex Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CCL.B	76 Outperform	$15.00B	18.76	14.88%	1.46%	7.12%	17.15%
CCL.A	74 Outperform	C$15.00B	19.02	15.16%	1.44%	7.12%	17.15%
WPK	73 Outperform	C$2.67B	14.29	10.45%	7.11%	3.19%	-0.26%
SXP	67 Neutral	C$87.14M	5.28	15.15%	19.66%	-4.69%	―
CAS	65 Neutral	$1.24B	61.94	1.16%	3.90%	3.50%	―
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
IFX	47 Neutral	C$118.76M	89.06	2.09%	―	0.32%	-76.77%

Imaflex Corporate Events

Imaflex Inc. Reports Q3 2025 Financial Results Amid Market Challenges

Imaflex Inc. reported a slight decline in revenues for Q3 2025, with $27.5 million compared to $28.4 million in 2024, amid challenging market conditions such as trade uncertainty and inflationary pressures. Despite these challenges, the company maintained profitability and a strong liquidity position, with $23.9 million available at the quarter’s end. The company remains optimistic about strengthening market fundamentals and is implementing targeted pricing and product mix strategies to stabilize performance, although margins have been impacted.